Archives: Speakers

have over 30 years of experience in the global pharmaceutical and biological industry and in healthcare IT, both at the helm of operations (from business unit head to general manager and CEO) and in marketing and commercial positions (from product marketing at country level to global marketing strategy). Through these local and global positions, I have acquired direct experience with blockbuster products in diverse markets (primary care, specialty care, hospital, vaccines, and biotechnology), geographies (US, Europe, Japan, China, India, Emerging Markets) and organizations.

An accomplished start-up and small pharma entrepreneurial scientist with extensive knowledge, experience, and achievement in a wide range of drug discovery and development programs. A respected leader of multi-disciplinary research teams with a strong record of identifying and developing novel assets whether emerging therapeutic targets or novel compounds, ranging from small molecules to biologicals. Experienced in both sell-side and buy-side deal crafting with a strong understanding of the requirements for raising capital and how to manage programs on limited budgets and tight time lines, including the use of virtual resources to achieve corporate goals

Over 20 years of R&D experience in Biotech and Big Pharma, with focus on the development of biotherapeutics and novel therapeutic platforms in oncology. Core expertise in oncology and immune-oncology research and development, spanning from target identification and validation, selection of therapeutic modalities and lead compounds, development of companion diagnostics, translational support for early clinical development and regulatory filings. As CSO and SVP of 3 T Biosciences, Hanspeter is overseeing platform- and therapeutic program development of novel classes of TCR based therapies to enable differentiated, innovative and transformational, cancer therapeutics that impact patients’ lives significantly.

Leadership of the Global Analytical Harmonization and Modernization organization within Global Quality reponsible for driving robustness, harmonization and modernization strategies and programs across GSK Vaccines with the intent to improve quality and timely QC testing

Dr. Diaz-Mitoma is a renowned medical scientist and professor who most recently served as a professor of the Northern Ontario School of Medicine (“NOSM”). While in this position, Dr. Diaz-Mitoma was Vice President of Research at Health Sciences North and founder of the Advanced Medical Research Institute of Canada (“AMRIC”) and served as its Chief Executive Officer and Chief Scientist. AMRIC is focused on translational medical and vaccine development research. Prior to joining the faculty at the NOSM, Dr. Diaz-Mitoma was a professor of Pediatrics, Pathology, Laboratory Medicine, and Microbiology at the University of Ottawa. While in this position, he founded the Vaccine and Infectious Disease Centre at the Children’s Hospital of Eastern Ontario (“CHEO”), a pediatric health and research center. Dr. Diaz-Mitoma received his medical degree from the University of Guadalajara, completed fellowship training in Infectious Diseases at the University of Manitoba, and earned a Ph.D. in Virology from the University of Alberta